| International consensus diagnostic criteria for neuromyelitis optica spectrum disorders DM Wingerchuk, B Banwell, JL Bennett, P Cabre, W Carroll, T Chitnis, ... Neurology 85 (2), 177-189, 2015 | 4551 | 2015 |
| A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking CE Teunissen, A Petzold, JL Bennett, FS Berven, L Brundin, M Comabella, ... Neurology 73 (22), 1914-1922, 2009 | 810 | 2009 |
| Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria B Banwell, JL Bennett, R Marignier, HJ Kim, F Brilot, EP Flanagan, ... The Lancet Neurology 22 (3), 268-282, 2023 | 668 | 2023 |
| MRI characteristics of neuromyelitis optica spectrum disorder: an international update HJ Kim, F Paul, MA Lana-Peixoto, S Tenembaum, N Asgari, J Palace, ... Neurology 84 (11), 1165-1173, 2015 | 663 | 2015 |
| Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial BAC Cree, JL Bennett, HJ Kim, BG Weinshenker, SJ Pittock, ... The Lancet 394 (10206), 1352-1363, 2019 | 661 | 2019 |
| Intrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis optica JL Bennett, C Lam, SR Kalluri, P Saikali, K Bautista, C Dupree, ... Annals of Neurology: Official Journal of the American Neurological …, 2009 | 643 | 2009 |
| Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72. 3 VG Johnson, J Schlom, AJ Paterson, J Bennett, JL Magnani, D Colcher Cancer research 46 (2), 850-857, 1986 | 567 | 1986 |
| Myelin-oligodendrocyte glycoprotein antibody-associated disease R Marignier, Y Hacohen, A Cobo-Calvo, AK Pröbstel, O Aktas, ... The Lancet Neurology 20 (9), 762-772, 2021 | 436 | 2021 |
| Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial A Traboulsee, BM Greenberg, JL Bennett, L Szczechowski, E Fox, ... The Lancet Neurology 19 (5), 402-412, 2020 | 435 | 2020 |
| Potassium channel KIR4. 1 as an immune target in multiple sclerosis R Srivastava, M Aslam, SR Kalluri, L Schirmer, D Buck, B Tackenberg, ... New England Journal of Medicine 367 (2), 115-123, 2012 | 426 | 2012 |
| Myelin oligodendrocyte glycoprotein antibody–positive optic neuritis: clinical characteristics, radiologic clues, and outcome JJ Chen, EP Flanagan, J Jitprapaikulsan, ASS López-Chiriboga, JP Fryer, ... American journal of ophthalmology 195, 8-15, 2018 | 375 | 2018 |
| Treatment of neuromyelitis optica: state-of-the-art and emerging therapies MC Papadopoulos, JL Bennett, AS Verkman Nature Reviews Neurology 10 (9), 493-506, 2014 | 346 | 2014 |
| Neuromyelitis optica and multiple sclerosis: seeing differences through optical coherence tomography JL Bennett, J de Seze, M Lana-Peixoto, J Palace, A Waldman, ... Multiple Sclerosis Journal 21 (6), 678-688, 2015 | 302 | 2015 |
| Anti–Aquaporin‐4 monoclonal antibody blocker therapy for neuromyelitis optica L Tradtrantip, H Zhang, S Saadoun, PW Phuan, C Lam, ... Annals of neurology 71 (3), 314-322, 2012 | 296 | 2012 |
| High resolution evoked potential imaging of the cortical dynamics of human working memory A Gevins, ME Smith, J Le, H Leong, J Bennett, N Martin, L McEvoy, R Du, ... Electroencephalography and clinical Neurophysiology 98 (4), 327-348, 1996 | 291 | 1996 |
| Impairment of mitochondrial transcription termination by a point mutation associated with the MELAS subgroup of mitochondrial encephalomyopathies JF Hess, MA Parisi, JL Bennett, DA Clayton Nature 351 (6323), 236-239, 1991 | 291 | 1991 |
| Isolated third, fourth, and sixth cranial nerve palsies from presumed microvascular versus other causes: a prospective study MA Tamhankar, V Biousse, GS Ying, S Prasad, PS Subramanian, MS Lee, ... Ophthalmology 120 (11), 2264-2269, 2013 | 275 | 2013 |
| Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trial C Zhang, M Zhang, W Qiu, H Ma, X Zhang, Z Zhu, CS Yang, D Jia, ... The Lancet Neurology 19 (5), 391-401, 2020 | 262 | 2020 |
| Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis SA Sargsyan, AJ Shearer, AM Ritchie, MP Burgoon, S Anderson, ... Neurology 74 (14), 1127-1135, 2010 | 246 | 2010 |
| Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid GP Owens, JL Bennett, H Lassmann, KC O'Connor, AM Ritchie, ... Annals of Neurology: Official Journal of the American Neurological …, 2009 | 238 | 2009 |
